Do not use Ortho Evra patches — or any other drugs — ordered from the Web site www.rxpharmacy.ws, ... Instead of the official patch, with its special sealed packaging and company label, ...

Ortho Evra sales last year totaled $124 million, trailing Merck & Co. Inc.’s NuvaRing, which posted sales of $437 million, according to health care data firm IMS Health.

Johnson & Johnson’s Ortho Evra contraceptive patch will come with a new warning about a study suggesting users could face twice the risks of blood clots compared with birth control pills, the ...

J&J;’s willingness to settle Ortho Evra lawsuits contrasts with Merck & Co.’s stance on the 11,500 suits it faces over painkiller Vioxx, which is linked to heart attacks and strokes.

The FDA is running out of excuses for not making a decision about Ortho Evra. The history is a long one, and it reflects badly on J&J: The patch has killed more than 40 women .

The maker and distributor of a widely used once-a-week birth control patch were the targets of lawsuits filed Wednesday in San Francisco by the mother of a 25-year-old woman who died after using ...

The Food and Drug Administration warned users of the popular Ortho Evra birth control patch that they are being exposed to more hormones, and are therefore at higher risk of blood clots and other ...

The Food and Drug Administration warned users of the popular Ortho Evra birth control patch that they are being exposed to more hormones, and are therefore at higher risk of blood clots and other ...

Ortho Evra is a prescription patch containing ethinyl estradiol and norelgestromin. The FDA notes that women using the product will be exposed to about 60% more estrogen than if they were using ...

When Ortho Evra first hit the market in 2002, it was a big hit. "Time" magazine called it one of the best inventions of the year and doctors have written nearly 40 million prescriptions for it.